Search by Drug Name or NDC
NDC 00002-8011-27 Omvoh 100 mg/mL Details
Omvoh 100 mg/mL
Omvoh is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is MIRIKIZUMAB.
Product Information
| NDC | 00002-8011 |
|---|---|
| Product ID | 0002-8011_83c555b7-3807-4f0b-8812-63b6082d026c |
| Associated GPIs | |
| GCN Sequence Number | 085439 |
| GCN Sequence Number Description | mirikizumab-mrkz PEN INJCTR 100 MG/ML SUBCUT |
| HIC3 | V4E |
| HIC3 Description | IL-23 RECEPTOR ANTAGONIST, MONOCLONAL ANTIBODY |
| GCN | 54920 |
| HICL Sequence Number | 049282 |
| HICL Sequence Number Description | MIRIKIZUMAB-MRKZ |
| Brand/Generic | Brand |
| Proprietary Name | Omvoh |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | mirikizumab-mrkz |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | MIRIKIZUMAB |
| Labeler Name | Eli Lilly and Company |
| Pharmaceutical Class | Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761279 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00002-8011-27 (00002801127)
| NDC Package Code | 0002-8011-27 |
|---|---|
| Billing NDC | 00002801127 |
| Package | 2 SYRINGE in 1 CARTON (0002-8011-27) / 1 mL in 1 SYRINGE (0002-8011-01) |
| Marketing Start Date | 2023-10-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |